Baidu
map

研究人员开发出检测假冒镇痛药新技术

2012-09-19 向明伟 中国科学报

    世界卫生组织(WHO)估计在发展中国家的药品供应中,至少有10%是假药,每年有数***因此而死亡。美国圣玛丽学院的研究人员研发了一种成本低廉的方法,可以精确地检测假冒的镇痛药,为同样掺假的一些药物的检测铺平了道路。     测试包括化学处理过的、一张名片大小的纸张。要检查是否有假冒的成分,只需要简单地将药丸刷在纸张上,并在水中蘸湿

    世界卫生组织(WHO)估计在发展中国家的药品供应中,至少有10%是假药,每年有数***因此而死亡。美国圣玛丽学院的研究人员研发了一种成本低廉的方法,可以精确地检测假冒的镇痛药,为同样掺假的一些药物的检测铺平了道路。

    测试包括化学处理过的、一张名片大小的纸张。要检查是否有假冒的成分,只需要简单地将药丸刷在纸张上,并在水中蘸湿纸张。纸张上的颜色变化表示药品里面有怀疑的成分。

    该研究小组重点对市场上销售的扑热息痛进行了研究,这是在世界上最为常见的伪造药物之一。该小组成功地验证了测试超过500份药物,包括作为对照组的造假成分。该研究成果在第244届美国化学会全国会议暨展览会上得以展示。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1907414, encodeId=ce6f190e41429, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Fri Apr 26 14:54:00 CST 2013, time=2013-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903642, encodeId=5690190364260, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Wed Jun 12 10:54:00 CST 2013, time=2013-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355192, encodeId=d0c61355192df, content=<a href='/topic/show?id=256a96e9990' target=_blank style='color:#2F92EE;'>#镇痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96799, encryptionId=256a96e9990, topicName=镇痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513497, encodeId=8c07151349e2a, content=<a href='/topic/show?id=16b62e53113' target=_blank style='color:#2F92EE;'>#假冒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27531, encryptionId=16b62e53113, topicName=假冒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d00d10562562, createdName=124987e8m10暂无昵称, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579715, encodeId=5e5715e971582, content=<a href='/topic/show?id=567c96806cc' target=_blank style='color:#2F92EE;'>#镇痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96806, encryptionId=567c96806cc, topicName=镇痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4d16558274, createdName=ms9476844295372110, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1907414, encodeId=ce6f190e41429, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Fri Apr 26 14:54:00 CST 2013, time=2013-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903642, encodeId=5690190364260, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Wed Jun 12 10:54:00 CST 2013, time=2013-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355192, encodeId=d0c61355192df, content=<a href='/topic/show?id=256a96e9990' target=_blank style='color:#2F92EE;'>#镇痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96799, encryptionId=256a96e9990, topicName=镇痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513497, encodeId=8c07151349e2a, content=<a href='/topic/show?id=16b62e53113' target=_blank style='color:#2F92EE;'>#假冒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27531, encryptionId=16b62e53113, topicName=假冒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d00d10562562, createdName=124987e8m10暂无昵称, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579715, encodeId=5e5715e971582, content=<a href='/topic/show?id=567c96806cc' target=_blank style='color:#2F92EE;'>#镇痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96806, encryptionId=567c96806cc, topicName=镇痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4d16558274, createdName=ms9476844295372110, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1907414, encodeId=ce6f190e41429, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Fri Apr 26 14:54:00 CST 2013, time=2013-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903642, encodeId=5690190364260, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Wed Jun 12 10:54:00 CST 2013, time=2013-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355192, encodeId=d0c61355192df, content=<a href='/topic/show?id=256a96e9990' target=_blank style='color:#2F92EE;'>#镇痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96799, encryptionId=256a96e9990, topicName=镇痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513497, encodeId=8c07151349e2a, content=<a href='/topic/show?id=16b62e53113' target=_blank style='color:#2F92EE;'>#假冒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27531, encryptionId=16b62e53113, topicName=假冒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d00d10562562, createdName=124987e8m10暂无昵称, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579715, encodeId=5e5715e971582, content=<a href='/topic/show?id=567c96806cc' target=_blank style='color:#2F92EE;'>#镇痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96806, encryptionId=567c96806cc, topicName=镇痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4d16558274, createdName=ms9476844295372110, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=)]
    2012-09-21 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=1907414, encodeId=ce6f190e41429, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Fri Apr 26 14:54:00 CST 2013, time=2013-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903642, encodeId=5690190364260, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Wed Jun 12 10:54:00 CST 2013, time=2013-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355192, encodeId=d0c61355192df, content=<a href='/topic/show?id=256a96e9990' target=_blank style='color:#2F92EE;'>#镇痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96799, encryptionId=256a96e9990, topicName=镇痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513497, encodeId=8c07151349e2a, content=<a href='/topic/show?id=16b62e53113' target=_blank style='color:#2F92EE;'>#假冒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27531, encryptionId=16b62e53113, topicName=假冒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d00d10562562, createdName=124987e8m10暂无昵称, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579715, encodeId=5e5715e971582, content=<a href='/topic/show?id=567c96806cc' target=_blank style='color:#2F92EE;'>#镇痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96806, encryptionId=567c96806cc, topicName=镇痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4d16558274, createdName=ms9476844295372110, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1907414, encodeId=ce6f190e41429, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Fri Apr 26 14:54:00 CST 2013, time=2013-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903642, encodeId=5690190364260, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Wed Jun 12 10:54:00 CST 2013, time=2013-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355192, encodeId=d0c61355192df, content=<a href='/topic/show?id=256a96e9990' target=_blank style='color:#2F92EE;'>#镇痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96799, encryptionId=256a96e9990, topicName=镇痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513497, encodeId=8c07151349e2a, content=<a href='/topic/show?id=16b62e53113' target=_blank style='color:#2F92EE;'>#假冒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27531, encryptionId=16b62e53113, topicName=假冒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d00d10562562, createdName=124987e8m10暂无昵称, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579715, encodeId=5e5715e971582, content=<a href='/topic/show?id=567c96806cc' target=_blank style='color:#2F92EE;'>#镇痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96806, encryptionId=567c96806cc, topicName=镇痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4d16558274, createdName=ms9476844295372110, createdTime=Fri Sep 21 01:54:00 CST 2012, time=2012-09-21, status=1, ipAttribution=)]
Baidu
map
Baidu
map
Baidu
map